Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-β-lactam-susceptible phenotype in Enterobacteriaceae : implications for selective reporting-Reference-Cited by-同舟云学术

Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-β-lactam-susceptible phenotype in Enterobacteriaceae : implications for selective reporting

Published:2017-08 Issue:8 Volume:23 Page:581-582
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Stainton S.M.,Thabit A.K.,Kuti J.L.,Aslanzadeh J.,Nicolau D.P.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference5 articles.

1. Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae;Nguyen;J Antimicrob Chemother,2014

2. β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?;Harris;Lancet Infect Dis,2015

3. Susceptibility profile of ceftolozane/tazobactam and other parenteral antimicrobials against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa from US hospitals;Sutherland;Clin Ther,2015

4. M100S Performance Standards for Antimicrobial Susceptibility Testing;The Clinical and Laboratory Standards Institute,2016

5. Detection of piperacillin-tazobactam-resistant/pan-β-lactam-susceptible Escherichia coli with current automated susceptibility test systems;Monogue;Infect Control Hosp Epidemiol,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection;Journal of Antimicrobial Chemotherapy;2024-05-06

2. Treatment of Piperacillin-Tazobactam–Nonsusceptible/Ceftriaxone-Susceptible Infections With Carbapenem Versus Carbapenem-Sparing Antimicrobials;Open Forum Infectious Diseases;2023-06-01

3. Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance;European Journal of Hospital Pharmacy;2022-02-21

4. Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B;Nature Communications;2020-10-01

5. SHV Hyperproduction as a Mechanism for Piperacillin–Tazobactam Resistance in Extended-Spectrum Cephalosporin-Susceptible Klebsiella pneumoniae;Microbial Drug Resistance;2020-04-01